» Articles » PMID: 31364532

The Epidemiology of Paediatric Mycoplasma Pneumoniae Pneumonia in North China: 2006 to 2016

Overview
Date 2019 Aug 1
PMID 31364532
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Paediatric Mycoplasma pneumoniae pneumonia (MPP) is a major cause of community-acquired pneumonia in China. Data on epidemiology of paediatric MPP from China are little known. This study retrospectively collected data from June 2006 to June 2016 in Beijing Children's Hospital, Capital Medical University of North China and aims to explore the epidemiological features of paediatric MPP and severe MPP (SMPP) in North China during the past 10 years. A total of 27 498 paediatric patients with pneumonia were enrolled. Among them, 37.5% of paediatric patients had MPP. In this area, an epidemic took place every 2-3 years at the peak, and the positive rate of MPP increased during these peak years over time. The peak age of MPP was between the ages of 6 and 10 years, accounting for 75.2%, significantly more compared with other age groups (χ2 = 1384.1, P < 0.0001). The epidemics peaked in September, October and November (χ2 = 904.9, P < 0.0001). Additionally, 13.0% of MPP paediatric patients were SMPP, but over time, the rate of SMPP increased, reaching 42.6% in 2016. The mean age of paediatric patients with SMPP (6.7 ± 3.0 years old) was younger than that of patients with non-SMPP (7.4 ± 3.2 years old) (t = 3.60, P = 0.0001). The prevalence of MPP and SMPP is common in China, especially in children from 6 to 10 years old. Paediatric patients with SMPP tend to be younger than those with non-SMPP. MPP outbreaks occur every 2-3 years in North China. September, October and November are the peak months, unlike in South China. Understanding the epidemiological characteristics of paediatric MPP can contribute to timely treatment and diagnosis, and may improve the prognosis of children with SMPP.

Citing Articles

Prevalence and distribution of respiratory pathogens in pediatric acute respiratory infections in Putian, China.

Zhu J, Wu S, Chen Y, Zheng L BMC Infect Dis. 2025; 25(1):278.

PMID: 40012061 PMC: 11863460. DOI: 10.1186/s12879-025-10670-7.


The impact of Mycoplasma pneumoniae infection on platelets in children with immune thrombocytopenia: a real-world study from China.

Wang N, Wang Z, Ouyang J, Ma J, Wei Y, Hu Y Ann Hematol. 2025; 104(1):105-110.

PMID: 39856251 PMC: 11868126. DOI: 10.1007/s00277-024-06179-9.


Predictive value of plasma sB7-H3 and YKL-40 in pediatric refractory Mycoplasma pneumoniae pneumonia.

Zhao Q, Ji S, Jiang H, Lu D, Qian L, Zhang J Open Med (Wars). 2025; 20(1):20241114.

PMID: 39822987 PMC: 11737367. DOI: 10.1515/med-2024-1114.


The virome composition of respiratory tract changes in school-aged children with Mycoplasma pneumoniae infection.

Zhang D, Cao Y, Dai B, Zhang T, Jin X, Lan Q Virol J. 2025; 22(1):10.

PMID: 39806507 PMC: 11731546. DOI: 10.1186/s12985-025-02626-9.


Reviewing advancement in P30 adhesin protein provides insights for future diagnosis and treatment.

Zuo Y, Zhang R, Li S Front Microbiol. 2024; 15:1515291.

PMID: 39735188 PMC: 11671514. DOI: 10.3389/fmicb.2024.1515291.


References
1.
Ito I, Ishida T, Osawa M, Arita M, Hashimoto T, Hongo T . Culturally verified Mycoplasma pneumoniae pneumonia in Japan: a long-term observation from 1979-99. Epidemiol Infect. 2001; 127(2):365-7. PMC: 2869758. DOI: 10.1017/s0950268801005982. View

2.
Bosnak M, Dikici B, Bosnak V, Dogru O, Ozkan I, Ceylan A . Prevalence of Mycoplasma pneumoniae in children in Diyarbakir, the south-east of Turkey. Pediatr Int. 2002; 44(5):510-2. DOI: 10.1046/j.1442-200x.2002.01606.x. View

3.
Puljiz I, Kuzman I, Dakovic-Rode O, Schonwald N, Mise B . Chlamydia pneumoniae and Mycoplasma pneumoniae pneumonia: comparison of clinical, epidemiological characteristics and laboratory profiles. Epidemiol Infect. 2005; 134(3):548-55. PMC: 2870427. DOI: 10.1017/S0950268805005522. View

4.
Othman N, Isaacs D, Kesson A . Mycoplasma pneumoniae infections in Australian children. J Paediatr Child Health. 2006; 41(12):671-6. DOI: 10.1111/j.1440-1754.2005.00757.x. View

5.
Vervloet L, Marguet C, Camargos P . Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias. Braz J Infect Dis. 2007; 11(5):507-14. DOI: 10.1590/s1413-86702007000500012. View